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Abstract
 
The cellular source of B cell activation factor (BAFF) required for peripheral B cell survival/
maturation is unknown. To determine the nature of BAFF-producing cells we established and
analyzed reciprocal bone marrow (BM) chimeras with wild-type (WT) and BAFF-deficient
mice. The results revealed that BAFF production by radiation-resistant stromal cells is com-
pletely sufficient to provide a necessary signal for B cell survival/maturation, as 
 
BAFF
 
 
 
/
 
 
 
 BM
cells transferred into lethally irradiated WT mice gave rise to normal numbers of follicular (FO)
and marginal zone (MZ) B cell subpopulations. On the other hand, transfer of WT BM into
 
BAFF
 
 
 
/
 
  
 
lethally irradiated mice resulted only in minimal reconstitution of mature FO B cells
and no restoration of MZ B cells. Thus, in the absence of 
 
BAFF
 
 
 
/
 
  
 
stromal cells, BAFF pro-
duction by BM-derived cells, presumably by macrophages, dendritic cells, and/or neutrophils,
was not at all sufficient to support normal B cell homeostasis. Interestingly, immunization of
both types of chimeras stimulated high levels of antigen-specific antibody secretion, indicating
that either stromal cell– or hematopoietic cell–derived BAFF is sufficient for B cell antibody
responses.
Key words: BAFF • B cells • homeostasis • bone marrow • stromal cells
 
Introduction
 
B cell activation factor (BAFF; also known as BLyS,
TALL-1, THANK, and zTNF4; 1–4) has been recently
shown to play a critical role in B cell development and
homeostasis. Specifically, mice rendered BAFF deficient
through homologous recombination or by treatment with
BAFF-blocking reagent (e.g., BCMA-Fc) have a dramati-
cally reduced B cell compartment (5, 6). BAFF deficiency
most severely affected mature follicular (FO; CD21
 
interm
 
CD23
 
high
 
) and marginal zone (MZ; CD21
 
high 
 
CD23
 
interm
 
) B
cell subpopulations, indicating that BAFF is required for
their maturation and/or survival. BAFF is further required
for humoral immune responses, as mice lacking the protein
display severely reduced antibody titers in response to both
T-dependent and T-independent antigens (6–8).
Although KO animals have unequivocally demonstrated
requirement for BAFF in B cell homeostasis and function,
the cellular source(s) of BAFF production required for
these functions has remained unknown. Macrophages,
DCs, and neutrophils have all been shown to be capable of
BAFF production in vitro (4, 9–11). The level of BAFF ex-
pression by these cells is especially notable upon stimulation
with proinflammatory stimuli such as IFN-
 
  
 
or IFN-
 
 
 
.
However, their ability to produce physiologically relevant
levels of BAFF in vivo has not been determined. We have
previously shown that BAFF plays a crucial role in B cell
homeostasis in the absence of any notable inflammation
and hence IFN production, as 
 
BAFF
 
-deficient mice have
only 
 
 
 
10% of normal B cell numbers (6). Furthermore,
because in the spleen both macrophages and DCs are localized
around the B cell area (in MZ and in T cell area) but not
directly in the B cell follicle (12), and hence not in the
immediate vicinity of most B cells, it is not clear whether
BAFF production by macrophages and DCs in vivo under
noninflammatory conditions is sufficient for maintenance
of B cell homeostasis.
To identify the cells producing BAFF required for B cell
homeostasis in vivo, we have used WT and 
 
BAFF
 
-deficient
animals to generate reciprocal BM chimeras. Lethally irra-
diated 
 
BAFF
 
 
 
/
 
  
 
mice reconstituted with WT BM contain
cells of hematopoietic origin (e.g., macrophages, DCs, and
neutrophils) that are capable of producing BAFF, whereas
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Abbreviations used in this paper:
 
 ASC, antibody-secreting cell; BAFF, B cell
activation factor; FO, follicular; GC, germinal center; MZ, marginal zone.T
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the reciprocal chimeras contain only radiation-resistant cells
such as stromal cells, which are capable of BAFF produc-
tion. By analyzing B cells from all of these mice we dem-
onstrated that radiation-resistant stromal cells are the major
in vivo source of BAFF required for B cell homeostasis.
 
Materials and Methods
 
Mice and BM Chimeras.
 
All mice used in our studies have
been housed at Biogen Inc.’s animal facility under specific
pathogen-free conditions. Animal experiments were approved
by the institutional animal care and use committee. 
 
BAFF
 
-defi-
cient mice were derived as previously described (6) and back-
crossed with C57BL6 mice (The Jackson Laboratory) for at least
four generations before intercrossing them to obtain 
 
BAFF
 
 
 
/
 
 
 
mice. 
 
BAFF
 
 
 
/
 
  
 
littermates were used as WT controls. B6.SJL
(CD45.1) mice were obtained from The Jackson Laboratory and
bred at Biogen Inc.’s animal facility. BM chimeras were con-
structed by i.v. injection of 6.5 
 
  
 
10
 
6 
 
donor-derived BM cells
into the recipient mice lethally irradiated with 950 rads at least
4–8 h prior. Mice were kept on a regular diet and acidified water
for 8 wk and used for the experiments 8–16 wk after the BM
transfer.
 
FACS
 
® 
 
Analyses.
 
Single cell suspensions from spleens or me-
senteric lymph nodes were prepared by grinding the organs in be-
tween the frosted sides of glass slides (Fisher Scientific), except
when staining for macrophages and DCs had to be performed. To
maximize the output of such cells, lymphoid organs were dissoci-
ated by treatment with 200 U/ml collagenase D (Roche) for 60
min at 37
 
 
 
C. For staining, cells were resuspended in FACS
 
® 
 
stain-
ing buffer (3% FBS, 0.1% Na
 
3
 
N PBS, pH 7.6) and after a brief
blocking step with anti-CD16/32 Fc-specific antibodies (BD
Biosciences), cells were stained with a mixture of specific anti-
bodies. All antibodies were from BD Biosciences. Cells were
fixed with Cytofix solution (BD Biosciences) before analyses on
BD Caliber (Becton Dickinson). FloJo
 
® 
 
(Tristar) software pack-
age was used to analyze the data.
 
Measuring the Antibody Response.
 
8–12 wk after BM transfer,
mice were immunized with 100 
 
 
 
g NP
 
21
 
-CGG conjugate (Bio-
search Technologies) precipitated in alum (Pierce Chemical
Co.). On day 10 after the immunization, mice were killed and
sera and lymphoid organs were collected to be evaluated by
ELISA, ELISPOT, and FACS
 
®
 
. The frequencies of antigen-spe-
cific antibody-secreting cells (ASCs) in the spleen were estimated
by ELISPOT assay. For ELISPOT assay mixed cellulose esters
(HA), 96-well plates (Millipore) were coated with NP
 
2
 
-BSA,
NP
 
17
 
-BSA, or CGG at 50 
 
 
 
g/ml in PBS overnight at 4
 
 
 
C. Plates
were washed twice and blocked by incubation with DMEM
supplemented with 5% FBS for 2 h before cell addition. 3 
 
  
 
10
 
5
 
spleen cells per well were cultured for 20 h at 37
 
 
 
C in 5% CO2
in complete media (DMEM supplemented with 5% FBS, 2-ME,
1% penicillin and streptomycin, and 1% 
 
l
 
-glutamine). Plates
were washed and spots were visualized using horseradish peroxi-
dase–conjugated goat anti–mouse IgG1 (Southern Biotechnol-
ogy Associates, Inc.) followed by AEC substrate (Zymogen).
The colorimetric reaction was stopped by washing the plates
with distilled water. The spots were counted with the aid of a
dissecting microscope.
ELISA for the levels of NP
 
2
 
- and NP
 
17
 
-specific IgG1 Igs in
sera of immunized mice was performed as previously described
(13). A serum from NP
 
21
 
-CGG hyperimmunized mouse was
used as a standard. Hyperimmunized mouse serum was obtained
from C57BL6 mice 6 d after being boosted with 50 
 
 
 
g NP
 
21
 
-
CGG in PBS, 30 d after primary challenge with 100 
 
 
 
g NP
 
17
 
-
CGG in alum. The level of antigen-specific Igs was expressed as
units of a reciprocal dilution of a standard serum sample.
 
Measuring BAFF Levels.
 
Generation of monoclonal murine
BAFF-specific antibodies and conditions for BAFF ELISA were
described elsewhere (unpublished data). Sensitivity of the ELISA
was 5 ng/ml.
 
Immunofluorescent Staining.
 
Spleens from different chimeric
animals were snap frozen in OCT compound. 0.5-
 
 
 
m thick
spleen sections were frozen after brief fixation in acetone and
kept at 
 
 
 
70
 
 
 
C until used. Frozen sections were defrosted, air
dried, and blocked with 0.2% Tween 20 1% BSA PBS, and then
Figure 1. Hematopoietic cells in
BM chimeras are of donor origin.
Lethally irradiated mice were recon-
stituted with 6.5   106 BM cells. 8–12
wk after reconstitution, single cell
suspensions were prepared by colla-
genase digestion of spleens from
B6.SJL BM→BAFF KO C57BL/6
(A), BAFF KO C57BL/6
BM→B6.SJL (B), and B6.SJL
BM→C57BL/6 (C) chimeric mice.
After gating, B220  (left), CD11c 
(middle), or CD11b   CD11c 
(right) cells were examined for
CD45.1 and CD45.2 expression.
Graphs are representative of six mice
per group examined.T
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stained with several antibody combinations: (a) anti-CD19 FITC
mAb and biotinylated anti-CD4 and anti-CD8 followed by stain-
ing with Streptavidin-Alexa Red594 conjugate (Molecular
Probes), (b) anti-CD11c FITC plus anti-CD11b FITC, anti-IgD
PE, and biotinylated anti-IgM followed by Streptavidin Alexa
Blue350 conjugate (Molecular Probes), and (c) anti–MOMA-1
FITC and anti-B220 biotin followed with Streptavidin-Alexa
Red594 conjugate (Molecular Probes). All antibodies were from
BD Biosciences, except for anti–MOMA-1 antibody, which was
from Serotec. After washing, slides were embedded in mounting
media with anti-fade ProLong compound (Molecular Probes) and
examined under Leica DMR microscope. Pictures were taken
with a Hammamatsu digital camera at 
 
 
 
200.
 
Statistics.
 
Unpaired Student’s 
 
t
 
 test was used to evaluate the
difference between two groups. To calculate the statistically sig-
nificant difference between the antibody titers and ELISPOT
data, Mann-Whitney nonparametric test was used. P 
 
  
 
0.050 was
considered to be statistically significant for both tests.
 
Results
 
Generation of BM Chimeras.
 
DCs, macrophages, and
neutrophils have all been shown to be capable of BAFF
production in vitro (4, 9, 10), but previous studies did not
establish their contribution to BAFF-dependent B cell de-
velopment in vivo. To investigate the cellular source of
BAFF in vivo, we created reciprocal BM chimeras with
WT and 
 
BAFF
 
-deficient mice. To distinguish between do-
nor- and recipient-derived cells in chimeric mice, we have
used C57BL6 and B6.SJL congenic mice that differ in the
expression of the CD45 allele. BM cells from C57BL6.SJL
(CD45.1
 
 
 
) mice were transferred into lethally irradiated
(950 rads) 
 
BAFF
 
 
 
/
 
  
 
(CD45.2
 
 
 
) mice (WT
 
→
 
KO) and vice
versa (KO
 
→
 
WT). As a control we have transferred BM
from C57BL6.SJL mice (CD45.1
 
 
 
) into lethally irradiated
congenic C57BL6 (CD45.2
 
 
 
) mice (WT
 
→
 
WT). 8 wk
after transplantation almost all macrophages (CD11b
 
 
 
CD11c
 
 
 
), DCs (CD11c
 
 
 
), B cells, and T cells were of do-
nor origin (Fig. 1 and unpublished data). Therefore, the
 
chimeric mice we have created are capable of producing
BAFF by all BM-derived cells including macrophages,
DCs, and neutrophils but not on radioresistant stromal cells
(WT
 
→
 
KO mice), or by only radioresistant stromal cells
(KO
 
→
 
WT mice) but not by any BM-derived cells. In the
control chimeras (WT
 
→
 
WT mice), all cells are competent
to produce BAFF.
 
Requirement for Radiation-resistant Stromal Cell–derived
BAFF in B Cell Homeostasis.
 
Analysis of B cells from
spleen and mesenteric lymph nodes from the chimeric mice
revealed (Table I and Fig. 2) that BAFF expression only by
radiation-resistant stromal cells (KO
 
→
 
WT mice) is com-
pletely sufficient to restore normal B cell numbers. In con-
trast, B cell homeostasis was still severely impaired in the ab-
sence of BAFF expression by stromal cells (WT
 
→
 
KO mice),
despite the presence of 
 
BAFF
 
 
 
/
 
  
 
macrophages and DCs.
Specifically, the proportion of B cells in the spleen and
lymph nodes from these mice was reduced relative to control
(WT
 
→
 
WT) mice (Fig. 2 A). Consistent with the reduction
in the percentage of B220
 
  
 
cells in the secondary lymphoid
organs, total B cell numbers in WT
 
→
 
KO mice were 3.5-
fold lower than in control WT
 
→
 
WT mice (Table I).
Although the total number of B cells in WT
 
→
 
KO mice
was only slightly higher (1.8-fold) than in mice completely
deficient in BAFF (KO), the numbers of specific B cell
subpopulations were differentially effected. Thus, FO B
cell (CD21
 
interm 
 
CD23
 
high
 
) numbers were fivefold higher
than in KO mice. In contrast, MZ B cell (CD21
 
high
 
CD23
 
low
 
) numbers are still just as deficient as in KO. To
get a better understanding of B cell differentiation in the
different chimeras and KO mice, we performed a FACS
 
®
 
analysis for CD21 and CD23 expression on B220
 
  
 
B cells.
Notably, as seen from Fig. 2 D, despite their reduced total
numbers and percentage within spleen or lymph nodes, FO
B cells in WT
 
→
 
KO chimeras represent a normal propor-
tion among remaining B cells in these mice. Therefore, in
the absence of stromal cell–derived BAFF, it appears that
BAFF production by macrophages, DCs, neutrophils, or
 
Table I.
 
Cellular Subset Distribution in Different Chimeric and BAFF
 
    
 
Mice
 
WT
 
→
 
KO KO
 
→
 
WT WT
 
→
 
WT KO
Total 35.21 
 
  
 
4.95
 
a
 
91.75 
 
  
 
10.9
 
b
 
86.76 
 
  
 
5.98
 
b 44.50   9.32a
B220  14.28   1.78a 64.26   5.01b 50.15   4.06b 8.65   0.78a
CD4  and CD8  16.47   2.40 25.82   2.52 23.94   1.60 21.93   2.13
CD11c  0.54   0.10a 1.30   0.25b 1.16   0.15b 0.44   0.02a
CD11b  2.10   0.66 1.78   0.22 1.70   0.17 1.52   0.26
FO (CD21interm CD23high) 8.04   1.03a,b 45.45   3.82b 38.93   4.18b 1.70   0.39a
MZ (CD21high CD23low) 0.41   0.12a 3.41   0.42b 3.68   0.37b 0.14   0.04a
NF (CD21  CD23 ) 2.89   0.53a 10.79   1.87 4.99   0.56 4.58   1.55
8–12 wk after the reconstitution of lethally irradiated (950 rads) mice with the BM, spleen cells were analyzed by FACS®. Mean cell numbers
 106   SD for each population are derived from 8–14 mice per group.
aSignificantly (P   0.01) different from the WT→WT mice.
bSignificantly (P   0.01) different from the KO mice.T
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other BM-derived cells is insufficient to maintain homeo-
stasis of MZ B cells and the majority of FO B cells.
Immunofluorescent staining of spleen sections from chi-
meric and BAFF-deficient mice (Fig. 3) supported the data
derived by FACS® analysis. BAFF production by stromal
cells alone (KO→WT) leads to reconstitution of the white
pulp with a normal proportion of B and T cells. In the
presence of only the BM cell–derived BAFF (WT→KO),
as a consequence of the reduced B cell zone the white pulp
area is smaller than normal, and mostly consists of T cells
similar to that observed in BAFF-deficient mice. IgD  B
cells are clearly more prevalent in WT→KO chimeras than
in BAFF-deficient mice, whereas IgMhigh MZ B cells were
just as scant. Interestingly, all mature IgD  B cells in
WT→KO chimeras are aligned along BAFF /  macro-
phages and DCs (CD11c  and CD11b ) that surround the
follicle. Staining for MZ B cells using markers for B cells
(B220) and metallophilic macrophages (MOMA-1), which
delineates the MZ from FO area, confirms the paucity of
MZ B cells in WT→KO mice (Fig. 3, bottom).
BAFF Production by Macrophages and DCs Is Sufficient for B
Cell Activation. BAFF /  mice are severely deficient in
mounting antibody responses to T cell–dependent antigens
(6). Although BAFF production by macrophages and DCs
was not sufficient to maintain normal numbers of mature B
cells in WT→KO mice, it is possible that BAFF production
by these cells will still be crucial in providing help to B cells
during their activation in vivo, as they can be found in the
close proximity to activated B cells (14). To investigate
whether BAFF production by either stromal cells or macro-
phages and DCs is sufficient to facilitate B cell activation
and differentiation, we immunized the BM chimeras with
NP21-CGG absorbed in alum 8–10 wk after BM reconstitu-
tion. BAFF KO mice were used as a control. 10 d later sera
Figure 2. BAFF     stromal
cells are necessary and sufficient
for complete reconstitution of
the B cell compartment. (A) B
cell reconstitution of secondary
lymphoid organs was evaluated
by FACS® analysis of spleens and
mesenteric lymph nodes from
different chimeric mice 8–12
weeks after BM transplantation.
(B) Spleen cells from these mice
were also evaluated for the ex-
pression of IgM and IgD (B), as
well as CD21 and CD23 (C).
CD21 and CD23 expression on
B cell after gating on B220  cells
is also shown (D). Numbers in
the quadrants or next to the
boxes indicate percentages of the
indicated population. MZ, FO,
and NF denote the gates used to
determine correspondingly MZ,
FO, and newly formed B cell
populations. Dot plots are repre-
sentative of four mice per group.
The experiment was repeated
five times with similar results.T
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Figure 3. Organization of the splenic B cell follicle in spleen requires BAFF    stroma. Frozen sections of spleens from different chimeras were stained
with anti-CD19 (green) and anti-CD4 plus anti-CD8 (red; top), anti-IgM (green), anti-IgD (red), and anti-CD11c plus CD11b (blue; middle), or anti–
MOMA-1 (green) and anti-B220 (red). Images of one representative section out of five spleens per group are shown.  200.
and spleens were taken from these mice and analyzed (Fig.
4). As can be seen from Fig. 4 A, all immunized mice have
similar frequencies of germinal center (GC) B cells (GL7 
IgD  B cells) among B220  cells in their spleens, although
absolute numbers of these cells in spleens of WT→KO chi-
meras and KO mice were still 3.5-fold and 6-fold lower
than in spleens of WT→WT or KO→WT mice. Despite
the similar frequencies of GC B cells in all mice, the fre-
quencies of antigen-specific IgG1 ASCs in spleens of BAFF
KO mice were the lowest as determined with ELISPOT as-
say (Fig. 4 B). The low frequency of ASCs in the spleens of
KO mice is in complete agreement with low titers of anti-
gen-specific IgG1 antibodies in sera of these mice (Fig. 4 B,
left; reference 6). Interestingly, although the frequency of
ASCs and titers of antigen-specific antibodies in WT→KO
mice were lower than in WT→WT mice, they were at least
10 times higher than in BAFF KO animals. High affinity (as
measured by their reactivity with NP2 antigen) antibodies
were also much higher in WT→KO mice than in KO
mice, indicating that affinity maturation can also be restored
by hematopoietic cell–derived BAFF. These data demon-
strate that BAFF production by DCs and macrophages is
sufficient to provide the level of BAFF necessary for the dif-
ferentiation of B cells into ASCs and consequently for anti-
body production. BAFF production by stromal cells was
also sufficient for both of these activities as the levels of
ASCs and antibodies in KO→WT mice were comparable
to those in WT→WT mice.
Stromal Cell Production of Systemic Levels of BAFF. Pre-
viously it has been demonstrated that sera from healthy
people have detectable levels of BAFF (15), suggesting that
some of the homeostatic functions of BAFF might be me-
diated by soluble rather than cell surface–expressed BAFF.
Because we observed that in WT→KO mice the mature
IgD  B cells are located in a thin layer next to BAFF-com-
petent CD11b  and CD11c  cells (Fig. 3), we speculated
that CD11c  and CD11b  cells are capable of producing
BAFF only locally but not systemically, which might be re-
quired to sustain a larger B cell follicle. To test the hypoth-
esis that only stromal radiation–resistant cells are the major
source of soluble systemic BAFF production, we checked
the level of BAFF in various generated chimeras 8–10 wk
after reconstitution. As seen from Fig. 5, a high systemic
level of BAFF in sera is achieved through the production
of BAFF by stromal cells (KO→WT mice) and not
through BM-derived macrophages, DCs, or neutrophils
(WT→KO).
Discussion
Our results clearly demonstrate that the major source of
BAFF required for normal B cell homeostasis is a radiore-
sistant cell population(s). BAFF production only by BM-
derived macrophages, DCs, or neutrophils is insufficient to
maintain normal B cell numbers. However, BM cell–
derived BAFF can drive differentiation of some immatureT
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newly formed B cells into mature FO, but not MZ, B cells.
Interestingly, BAFF production by BM-derived cells as
well as radioresistant cells could support B cell activation
and antibody production in response to immunization with
a T-dependent antigen.
Mice deficient in BAFF have greatly reduced numbers of
mature B cells in their lymphoid organs (6). Treatment of
mice with BAFF-blocking reagents like the soluble
BCMA-Fc receptor fusion molecule also leads to the disap-
pearance of mature B cells from the lymphoid organs (5).
These data indicate that there is a constant requirement for
BAFF-mediated signaling during B cell maturation as well
as for survival of mature B cells. Earlier in vitro studies
showed that monocytes and DCs can secrete BAFF and
also express it on their surface, particularly after activation
by proinflammatory stimuli including type I and II IFNs (4,
9). Similarly, G-CSF is capable of inducing BAFF produc-
tion by neutrophils (10). However, the macrophages, poly-
morphonuclear granulocytes, and DCs, which are found
around the splenic white pulp and in the red pulp, do not
localize precisely with most splenic B cells (12). Rather, the
distributions of these cells overlap mostly with the edges of
the MZ. Perhaps reflecting this, in spleens of WT→KO
chimeras (which contain BAFF /  BM-derived macro-
phages, DCs, and neutrophils) we observed B cell areas al-
most as small as in KO mice, and mature IgD  B cells
aligned in a narrow area along the surrounding CD11c 
and CD11b  cells. By contrast, the size of B cell areas in
KO→WT chimeras appeared normal, although all hemato-
poietic cells including macrophages, DCs, and neutrophils
in these mice are BAFF   . These findings cannot be ex-
plained by the continued presence of BM-derived host cells
because we unequivocally established the origin and geno-
type of hematopoietic cells through staining for CD45.1
and CD45.2 antigens at the time of analysis. 8 wk after
transplantation,  97% of macrophages (CD11b  CD11c )
Figure 5. Production of systemic levels of secreted BAFF in sera requires
BAFF    stromal cells. Sera from different chimeric mice 8–12 wk after
their reconstitution were assayed for BAFF levels by ELISA. Sera were
collected from 6–10 mice per group. *, statistically significant (P   0.05)
difference relative to the WT→WT mice. Limit of detection of this
ELISA was 5 ng/ml.
Figure 4. Both BM-derived
BAFF    and stroma BAFF    cells
can provide BAFF signal during
antigen-specific antibody response.
(A) 10 d after the immunization
with 100  g NP21-CGG in alum,
spleen cells from various chimeras
were analyzed for the presence of
GC B cells. Numbers in the squares
represent percent of GC (GL7 
IgD ) B cells among B220  cells in
spleens of the chimeric mice.
Graphs representative of six mice
per each group are shown. No sig-
nificant number of GL7   IgD 
B220  cells could be detected in
the absence of immunization. (B)
Spleen cells from the mice immu-
nized as in A were assayed for the
frequency of NP2- and NP17-specific
ASCs per 9   105 splenocytes using
ELISPOT assay (right). NP2- and
NP17-specific titers of IgG1 antibodies
in sera of different immunized chi-
meric mice were determined by
ELISA and expressed as a reciprocal
of standard sera dilution giving the
same OD450 as the sample (left). 6–10
mice per group were used in the
experiment. The values for all chi-
meric mice were statistically signifi-
cantly higher than the values from
BAFF /  (KO) mice (P   0.05).T
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and DCs (CD11c ) in all chimeric mice were donor de-
rived (Fig. 1). Although spleens of mice whose radiation-
resistant cells were BAFF     (i.e., WT→KO and KO
mice) contained approximately twofold fewer DCs than
normal (Table I), the reduction is, most likely, secondary to
the B cell deficiency in such mice. In fact, previous studies
have shown that B cells are required for normal repopula-
tion of spleens by DCs (16). Furthermore, in vitro cultures
of BM cells from BAFF    and WT mice gave rise to simi-
lar numbers of DCs (unpublished data).
It is very clear from our studies that even in the complete
absence of BAFF production by DCs, but in the presence
of  BAFF /  radiation-resistant stromal cells, the B cell
compartment is normal. Therefore, cells other than macro-
phages, DCs, and neutrophils contribute the majority of
BAFF production required for normal B cell homeostasis.
Splenic stromal cells, given their radioresistance and close
proximity to all cells in the spleen including developing B
lymphocytes (17, 18), are plausible candidates for produc-
tion of BAFF. Analysis of LT  receptor (LT R)-deficient
mice and radiation chimeras derived from these animals
demonstrated a crucial role for one type of stromal cell, FO
DCs, in chemokine production required to maintain nor-
mal architecture of B and T cell zones in the spleen (for re-
view see reference 19). It is tempting to speculate that in-
teraction of B cells and stromal cells (whereupon the B cells
provide LT  to LT R-expressing stromal cells) is respon-
sible not only for proper B cell localization in secondary
lymphoid organs, but also for BAFF-dependent B cell mat-
uration and survival. Interestingly, injection of LT R ago-
nist antibodies into mice leads to a dramatic increase of
BAFF mRNA expression in the spleen (20). However,
there must be an LT -independent source of BAFF pro-
duction, as LT -deficient mice have normal numbers of B
cells (21, 22). It is also important to mention in this regard
that it remains formally possible that radiation-resistant cells
outside of secondary lymphoid organs may contribute sub-
stantially to circulating levels of BAFF required for mainte-
nance of B cells. This would be consistent with our obser-
vation of circulating BAFF only in mice with BAFF / 
radiation-resistant cells (Fig. 5).
Despite a major requirement for additional BAFF from
other sources, its production solely by BM-derived cells
does play a role in normal immune responses. Our FACS®
and immunohistochemical analysis of radiation chimeras
whose macrophages, DCs, and neutrophils could produce
BAFF showed that signaling induced by these cells was suf-
ficient to induce maturation of some newly formed B cells
to mature FO B cells. Immature B cells constantly emerge
from the BM in large numbers, migrate to peripheral lym-
phoid organs, and then mostly die soon thereafter unless
they can receive a maturation and survival signal (23). De-
pending on the nature of that signal(s), they differentiate
into either FO B cells (CD21low CD23high) or MZ B cells
(CD21high CD23low; references 24 and 25). BAFF plays a
crucial role in that process. The lymphoid organs of BAFF-
deficient mice contain nearly normal numbers of immature
B cells, but almost completely lack FO and MZ B cell
compartments (6). In the presence of BAFF production by
BM-derived cells only (WT→KO chimeras), total B cell
numbers were still drastically reduced by comparison to
WT animals. However, the number of mature FO B cells
was significantly higher than in BAFF-deficient mice and
even comprised a normal proportion of FO B cells within
the remaining B cells (Fig. 2 D). Whether this small num-
ber of cells represents a subpopulation requiring less BAFF
for complete maturation remains unknown.
MZ B cells, despite their proximity to BM-derived
BAFF /   CD11b   cells in chimeric (WT→KO) mice,
were very poorly reconstituted for reasons that remain un-
clear. Lack of MZ B cells cannot simply be explained by
slow kinetics of reconstitution for these cells as we did not
detect any significant increase in the numbers of these cells
in WT→KO mice even 4 mo after BM reconstitution (un-
published data). Their absence may rather reflect an in-
creased requirement for circulating BAFF by this subpopu-
lation, a need for additional circulating BAFF-dependent
costimulatory factors, or some specific requirement by MZ
cells for direct cell–cell interaction with radiation-resistant
stromal cells that produce BAFF.
The importance of BAFF in supporting antigen-specific
B cell responses is further clarified by our studies. It was
previously known that BAFF deficiency or inhibition with
soluble receptor decoy molecules (BCMA-Fc and TACI-
Fc) significantly reduces antibody responses to a variety of
specific antigens (6–8). Our data demonstrate that BAFF
production by radiation-resistant cells or by BM-derived
cells is sufficient to support B cell responses. Both types of
chimeras created using BAFF     cells (WT→KO and
KO→WT) responded to NP21-CGG immunization with
frequencies of ASCs and antibody levels that significantly
exceeded those observed in BAFF    mice. Although the
frequency of ASCs and the level of antibodies in WT→KO
chimeras were smaller than in control (WT→WT) mice,
the reduced numbers of total mature B cells in these mice is
likely to account for this finding.
The antibody responses were fully supported only by ra-
diation-resistant cell-produced BAFF, suggesting that BAFF
production by BM-derived cells is redundant. However,
because we did not assay all aspects of the immune response,
e.g., memory B cell generation and maintenance, we can-
not completely exclude the possibility that BM-derived cells
represent an important and nonredundant source of BAFF
for maintenance of some of the immune responses. Our
data do not allow direct identification of a single population
of BAFF-producing cells in the spleen, which is crucial to
normal antibody responses. However, the findings are con-
sistent with previous observations showing DCs in close
contact with T and B cells during the antigen response in
vivo (26, 27). This may reflect a need for (B cell–expressed)
BAFF receptor, BAFF-R, to directly engage BAFF ex-
pressed on the DC surface. This need would be similar to
the requirement for direct interaction between B cells and
FO DCs during normal GC development. Alternately, rela-
tively close proximity of B lymphocytes to DCs producing
locally high concentrations of soluble BAFF may mediate BT
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cell survival and differentiation after antigen challenge. Both
of these possibilities are completely consistent with the
demonstrated role of DC-produced BAFF for plasmablast
generation (14) and during Ig class switching (11).
The studies of radiation chimeras described here estab-
lish that the most important source of BAFF for B cell ho-
meostasis originates from radiation-resistant stromal cells.
These findings may have significant implications for treat-
ment of certain B cell–mediated diseases. For example, au-
tologous BM transplantation is being considered for treat-
ment of SLE on the premise of “resetting” the immune
system (28). If some cases of lupus result from dysregulated
BAFF production, then those patients will likely fail to
benefit from the BM transplant as such a therapy would
not directly reset BAFF production by radiation-resistant
cells. Therefore, careful revision of these strategies may
need to be considered.
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